BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 18, 2026
Home
»
Topics
»
Disease categories and therapies
» Nephrology
Nephrology
RSS
Keryx Biopharmaceuticals provides update from safety extension study of Zerenex
Nov. 12, 2013
New Hsp70 inducers presented by scientists in the Netherlands
Nov. 11, 2013
Phase II trial of Zerenex in NDD-CKD meets all primary and key secondary endpoints
Nov. 7, 2013
Genkyotex begins multinational phase II study of NOX inhibitor
Nov. 5, 2013
Development of Kremezin discontinued in the U.S. and Europe
Oct. 31, 2013
Sophiris begins dosing in PLUS-1 phase III trial of PRX-302
Oct. 30, 2013
Enrollment complete in phase III trial of ZS-9 for treatment of hyperkalemia
Oct. 24, 2013
Evotec and AstraZeneca collaborate on treatments for chronic kidney disease
Oct. 22, 2013
Relypsa reports topline data from phase IIb trial of patiromer
Oct. 18, 2013
Phase I trial of KEA-0447/KRP-EPA605 for treatment of overactive bladder begins
Oct. 18, 2013
Previous
1
2
…
99
100
101
102
103
104
105
106
107
…
337
338
Next
RSS